tailieunhanh - Cervical Cancer Screening In Developing Countries - Report Of A WHO Consultation

This publication is the product of a comprehensive consultation undertaken by WHO in 2001 involving leading experts in the field of cancer epidemiology, screening and treatment. It is part of WHO's commitment to provide evidence-based guidelines to decision makers, and a recognition of the priority that should be given to cervical cancer screening and treatment as an essential component of any comprehensive national cancer control program. The report focuses particularly on the situation in low and middle income countries - countries in | in Developing Countries Report of a WHO consultation Published collaboratively by Programme on Cancer Control Department of Reproductive Health and Research World Health Organization Cervical Cancer Screening IN Developing Countries REPORT OF A WHO CONSULTATION WORLD HEALTH ORGANIZATION GENEVA WHO Library Cataloguing-in-Publication Data Cervical cancer screening in developing countries report of a WHO consultation. neoplasms - diagnosis techniques Obstetrical and gynaecological - utilization health programmes - organization and administration countries ISBN 92 4 154572 0 NLM LC classification WP 480 World Health Organization 2002 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination World Health Organization 20 Avenue Appia 1211 Geneva 27 Switzerland tel 41 22 791 2476 fax 41 22 791 4857 email bookorders@ . Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications at the above address fax 41 22 791 4806 email permissions@ . The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country territory city or area or of its authorities or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the